Mesa Laboratories (MLAB) shows promise with strong order growth and valuation potential, despite profitability challenges.

Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. Read what BMY stock has to offer ...

Hyundai's second high-performance EV will be unveiled at the Goodwood Festival of Speed and will bring bold bodywork, revised ...

Halma has been one of the UK’s best growth stocks for a long time. And at an unusually low valuation, should investors buy at ...

The Morgan Plus Four has the same sweeping fenders, cutaway doors, and long louvered hood that four-cylinder Morgans have had ...

Some fast food favorites are like old friends — comforting, reliable, and downright addictive. But then, out of nowhere, a ...

While the EXP Turbo Coupe never led its class in outright speed, its combination of compact dimensions, forced induction, and ...

Here's why Canadian retirees should consider gaining exposure to blue-chip TSX dividend stocks such as BNS and Fortis right ...

Former Obama economic advisor Jason Furman just dropped a reality check that should have every investor paying attention to ...

New Hampshire does not provide constitutionally adequate education funding for school districts, the state Supreme Court held Tuesday, in a major decision that could force sweeping legislative changes ...

The Punjab and Haryana High Court examined the Commissioner of Income Tax's powers under Section 263, emphasizing the conditions for exercising revisional ...

NAV Formula: Total Assets – Total ... Various factors such as historical performance, expense ratio and consistency of the fund are also considered. The NAV is also influenced by the capital gains, ...